Team:KIT-Kyoto/Parts
From 2010.igem.org
(Difference between revisions)
(Prototype team page) |
(→2.We obtained this part directly from iGEM HQ) |
||
(44 intermediate revisions not shown) | |||
Line 1: | Line 1: | ||
- | < | + | <html><head> |
+ | <style type=text/css> | ||
+ | .tblsample table, .tblsample tr, .tblsample td {border:0px; | ||
+ | cellpadding:5; | ||
+ | cellspacing:1; | ||
+ | bgcolor:none; | ||
+ | background:url(); | ||
- | <html> | + | } |
- | + | </style> | |
- | < | + | </head></html> |
- | + | {{Template:KIT-Kyoto/menu}} | |
- | < | + | <table border=0 width="965px" align="center"><tr><td> |
- | <div | + | <div aling="left">[[Team:KIT-Kyoto/Home|Home]] > [[Team:KIT-Kyoto/Parts|Parts]]</div></td><td><div align="right">Language : [[Team:KIT-Kyoto/Parts|English]] / [[Team:KIT-Kyoto/PartsJ|Japanese]]</div></td></tr></table> |
- | + | <div id="NAKAMI"> | |
- | < | + | |
- | <div | + | |
- | + | ||
- | </ | + | |
- | </ | + | |
- | < | + | |
- | + | == We used these parts for making our original biobrick parts == | |
+ | === 1.We obtained these parts from 2010 iGEM kit === | ||
- | + | {| style="margin: 1em auto 1em auto" width="750px" | |
- | {| | + | |- style="background-color:#c1e4e9;" |
- | | | + | !Name||Part type||Resistance||Insert||Vector||Contents |
- | | | + | |- style="background-color:#eaf4fc;" |
- | |- | + | |<partinfo>pSB3k3</partinfo>(<partinfo>BBa_J04450</partinfo>)||Plasmid backbone||Kanamycin||738bp||2750bp||promoter(LacI) +RBS+mRFP+T+T |
- | | | + | |- style="background-color:#eaf4fc;" |
- | + | |<partinfo>pSB6A1</partinfo>(<partinfo>BBa_J04450</partinfo>)||Plasmid backbone||Ampicillin||738bp||4032bp||promoter(LacI) +RBS+mRFP+T+T | |
- | | | + | |- style="background-color:#eaf4fc;" |
+ | |<partinfo>pSB1C3</partinfo>(<partinfo>BBa_J04450</partinfo>)||Plasmid backbone||Chloramphenicol||1069bp||2072bp||promoter(LacI) +RBS+mRFP+T+T | ||
+ | |- style="background-color:#eaf4fc;" | ||
+ | |<partinfo>pSB1A2</partinfo>(<partinfo>BBa_I3522</partinfo>)||Composite||Ampicillin||937bp||2079bp||promoter(TetR)+RBS+GFP+T+T | ||
+ | |- style="background-color:#eaf4fc;" | ||
+ | |<partinfo>pSB1A2</partinfo>(<partinfo>BBa_R0040</partinfo>)||Regulatory||Ampicillin||54bp||2079bp||promoter(TetR) | ||
+ | |- style="background-color:#eaf4fc;" | ||
+ | |<partinfo>pSB1A2</partinfo>(<partinfo>BBa_I732019</partinfo>)||Regulatory||Ampicillin||3230bp||2079bp||RBS+LacZ+T+T | ||
+ | |- style="background-color:#eaf4fc;" | ||
+ | |<partinfo>pSB1AK3</partinfo>(<partinfo>BBa_I732950</partinfo>)||Protein domain||Kanamycin||3230bp||2079bp||RBS+LacZ+T+T | ||
+ | |- style="background-color:#eaf4fc;" | ||
+ | |<partinfo>pSB4A5</partinfo>(<partinfo>BBa_K193602</partinfo>)||Composite||Ampicillin||1896bp||3395bp||promoter(LacIQ)+RBS+melA | ||
+ | |- style="background-color:#eaf4fc;" | ||
+ | |<partinfo>pSB1A2</partinfo>(<partinfo>BBa_E0240</partinfo>)||Protein domain||Ampicillin||883bp||2079bp||RBS+GFP+T+T | ||
+ | |- style="background-color:#eaf4fc;" | ||
+ | |<partinfo>pSB1A2</partinfo>(<partinfo>BBa_I13507</partinfo>)||Protein domain||Ampicillin||937bp||2079bp||RBS+RFP+T+T | ||
+ | |- style="background-color:#eaf4fc;" | ||
+ | |<partinfo>pSB1A2</partinfo>(<partinfo>BBa_E0420</partinfo>)||Protein domain||Ampicillin||878bp||2079bp||RBS+CFP+T+T | ||
+ | |- style="background-color:#eaf4fc;" | ||
+ | |<partinfo>pSB1A2</partinfo>(<partinfo>BBa_E0430</partinfo>)||Protein domain||Ampicillin||878bp||2079bp||RBS+YFP+T+T | ||
+ | |- style="background-color:#eaf4fc;" | ||
+ | |<partinfo>pSB1A2</partinfo>(<partinfo>BBa_I13600</partinfo>)||Composite||Ampicillin||940bp||2079bp||promoter(TetR)+RBS+CFP+T+T | ||
+ | |- style="background-color:#eaf4fc;" | ||
+ | |<partinfo>pSB1A2</partinfo>(<partinfo>BBa_J22005</partinfo>)||Composite||Ampicillin||2079bp||2623bp||promoter(TetR)+RBS+YFP+T+T | ||
|- | |- | ||
- | |||
- | |||
|} | |} | ||
- | + | === 2.We obtained this part directly from iGEM HQ === | |
+ | :We added new information to the BioBrick Part (pSB6A1) shown below that was originally developed by the 09’Tokyo-Tech group. This BioBrick Part having the backbone of pSB6, a low copy plasmid was designed to express GFP in <I>E. coli</I>. Generally low copy plasmid is more efficient in protein expression in compared with high copy plasmid such as pSB1. However no quantitative data on the efficiency of GFP expression with this plasmid was described in any site of iGEM. We therefore measured intensities of fluorescence of GFP protein produced in <I>E. coli</I> carrying the pSB6A1 and compared with that carrying the pSB1A2. The data clearly showed that expression level of GFP is much higher in E. coli carrying pSB6A1 than that carrying pSB1A2. Thus we decided to use pSB6 vector to measure activities of various promoters responsible to H<sub>2</sub>O<sub>2</sub>. We thank the 09’Tokyo-Tech group who has originally developed this part.This new information would be useful for the other iGEM teams in future. | ||
+ | <BR> | ||
+ | :[https://2010.igem.org/Team:KIT-Kyoto/Project/Abstract#2._Compare_the_performances_of_the_high_copy_vector_and_low_copy_vector >>About pSB1 vs pSB6] | ||
- | {| style=" | + | {| style="margin: 1em auto 1em auto" width="750px" |
- | ! | + | |- style="background-color:#c1e4e9;" |
- | + | !Name||Part Type||Resistance||Insert||Vector||Contents| | |
- | + | |- style="background-color:#eaf4fc;" | |
- | + | |<partinfo>pSB6A1</partinfo>(<partinfo>BBa_K121013</partinfo>)||Protein domain||Ampicillin||883bp||4022bp||RBS+GFP+T+T | |
- | + | ||
- | + | ||
- | + | ||
- | + | ||
|} | |} | ||
- | + | == We designed and constructed these parts originally. == | |
- | + | We cloned the following inserts into the vector, pSB6A1. Out of them we cloned the two inserts(BBa_K362005, BBa_K362007) into the pSB1C3 to send to the iGEM headquarter. | |
- | == | + | <div align="center"> |
- | + | ||
- | + | ||
- | + | ||
<groupparts>iGEM010 KIT-Kyoto</groupparts> | <groupparts>iGEM010 KIT-Kyoto</groupparts> | ||
+ | </div> | ||
+ | {{Template:KIT-Kyoto-1}} |
Latest revision as of 03:16, 27 October 2010
Home > Parts | Language : English / Japanese |
We used these parts for making our original biobrick parts
1.We obtained these parts from 2010 iGEM kit
Name | Part type | Resistance | Insert | Vector | Contents |
---|---|---|---|---|---|
<partinfo>pSB3k3</partinfo>(<partinfo>BBa_J04450</partinfo>) | Plasmid backbone | Kanamycin | 738bp | 2750bp | promoter(LacI) +RBS+mRFP+T+T |
<partinfo>pSB6A1</partinfo>(<partinfo>BBa_J04450</partinfo>) | Plasmid backbone | Ampicillin | 738bp | 4032bp | promoter(LacI) +RBS+mRFP+T+T |
<partinfo>pSB1C3</partinfo>(<partinfo>BBa_J04450</partinfo>) | Plasmid backbone | Chloramphenicol | 1069bp | 2072bp | promoter(LacI) +RBS+mRFP+T+T |
<partinfo>pSB1A2</partinfo>(<partinfo>BBa_I3522</partinfo>) | Composite | Ampicillin | 937bp | 2079bp | promoter(TetR)+RBS+GFP+T+T |
<partinfo>pSB1A2</partinfo>(<partinfo>BBa_R0040</partinfo>) | Regulatory | Ampicillin | 54bp | 2079bp | promoter(TetR) |
<partinfo>pSB1A2</partinfo>(<partinfo>BBa_I732019</partinfo>) | Regulatory | Ampicillin | 3230bp | 2079bp | RBS+LacZ+T+T |
<partinfo>pSB1AK3</partinfo>(<partinfo>BBa_I732950</partinfo>) | Protein domain | Kanamycin | 3230bp | 2079bp | RBS+LacZ+T+T |
<partinfo>pSB4A5</partinfo>(<partinfo>BBa_K193602</partinfo>) | Composite | Ampicillin | 1896bp | 3395bp | promoter(LacIQ)+RBS+melA |
<partinfo>pSB1A2</partinfo>(<partinfo>BBa_E0240</partinfo>) | Protein domain | Ampicillin | 883bp | 2079bp | RBS+GFP+T+T |
<partinfo>pSB1A2</partinfo>(<partinfo>BBa_I13507</partinfo>) | Protein domain | Ampicillin | 937bp | 2079bp | RBS+RFP+T+T |
<partinfo>pSB1A2</partinfo>(<partinfo>BBa_E0420</partinfo>) | Protein domain | Ampicillin | 878bp | 2079bp | RBS+CFP+T+T |
<partinfo>pSB1A2</partinfo>(<partinfo>BBa_E0430</partinfo>) | Protein domain | Ampicillin | 878bp | 2079bp | RBS+YFP+T+T |
<partinfo>pSB1A2</partinfo>(<partinfo>BBa_I13600</partinfo>) | Composite | Ampicillin | 940bp | 2079bp | promoter(TetR)+RBS+CFP+T+T |
<partinfo>pSB1A2</partinfo>(<partinfo>BBa_J22005</partinfo>) | Composite | Ampicillin | 2079bp | 2623bp | promoter(TetR)+RBS+YFP+T+T |
2.We obtained this part directly from iGEM HQ
- We added new information to the BioBrick Part (pSB6A1) shown below that was originally developed by the 09’Tokyo-Tech group. This BioBrick Part having the backbone of pSB6, a low copy plasmid was designed to express GFP in E. coli. Generally low copy plasmid is more efficient in protein expression in compared with high copy plasmid such as pSB1. However no quantitative data on the efficiency of GFP expression with this plasmid was described in any site of iGEM. We therefore measured intensities of fluorescence of GFP protein produced in E. coli carrying the pSB6A1 and compared with that carrying the pSB1A2. The data clearly showed that expression level of GFP is much higher in E. coli carrying pSB6A1 than that carrying pSB1A2. Thus we decided to use pSB6 vector to measure activities of various promoters responsible to H2O2. We thank the 09’Tokyo-Tech group who has originally developed this part.This new information would be useful for the other iGEM teams in future.
Name | Part Type | Resistance | Insert | Vector | |
---|---|---|---|---|---|
<partinfo>pSB6A1</partinfo>(<partinfo>BBa_K121013</partinfo>) | Protein domain | Ampicillin | 883bp | 4022bp | RBS+GFP+T+T |
We designed and constructed these parts originally.
We cloned the following inserts into the vector, pSB6A1. Out of them we cloned the two inserts(BBa_K362005, BBa_K362007) into the pSB1C3 to send to the iGEM headquarter.
<groupparts>iGEM010 KIT-Kyoto</groupparts>